Clinical Trial Update: Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates low-dose tamoxifen plus lifestyle changes for breast cancer prevention in individuals with BRCA mutations and other breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ
• Lobular Carcinoma in Situ

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: European Institute of Oncology | Conditions: BRCA Mutation, PALB2 Gene Mutation | Phase 2 | Status: ACTIVE_NOT_RECRUITING